DS
Therapeutic Areas
TippingPoint Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lead Program | Pediatric Diffuse Midline Glioma (DMG) | Pre-clinical |
Leadership Team at TippingPoint Biosciences
DL
Dr. Laura Hsieh
CEO & Founder
DG
Dr. Geeta Narlikar
Chair of SAB & Founder
DG
Dr. Gary Li
CSO
PC
Philamer Calses
Director of R&D